0001209191-13-050003.txt : 20131031 0001209191-13-050003.hdr.sgml : 20131031 20131031160912 ACCESSION NUMBER: 0001209191-13-050003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131029 FILED AS OF DATE: 20131031 DATE AS OF CHANGE: 20131031 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Connolly Thomas CENTRAL INDEX KEY: 0001453943 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 131182826 MAIL ADDRESS: STREET 1: 717 FIFTH AVENUE STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-10-29 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001453943 Connolly Thomas C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE, MA 02139 0 1 0 0 SVP, Human Resources Common Stock 2013-10-29 4 M 0 938 53.74 A 5940 D Common Stock 2013-10-29 4 S 0 100 72.68 D 5840 D Common Stock 2013-10-29 4 S 0 1000 75.00 D 4840 D Common Stock 2013-10-29 4 S 0 588 75.50 D 4252 D Common Stock 150 I 401(k) Stock Option (right to buy) 53.74 2013-10-29 4 M 0 938 0.00 D 2022-09-03 Common Stock 938 11250 D Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $75.00 (range $74.32 to $75.24). Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $75.50 (range $75.39 to $75.60). The option vests in 16 quarterly installments from 09/04/2012. Kenneth L. Horton, Attorney-In-Fact 2013-10-31